. home.aspx



AWS initiative to accelerate COVID-19 diagnostics, research

March 23, 2020 / Nathan Eddy

Amazon joins a growing list of global technology giants stepping up to help battle the global COVID-19 pandemic through the AWS Diagnostic Development Initiative, which aims to accelerate COVID-19 diagnostics, research, and testing. The program, which is backed by an initial investment of $20 million, is open to accredited research institutions and private entities using AWS to support research-oriented workloads for the development of point-of-care diagnostics. This type of diagnostic treatment refers to testing that can be done at home or at a clinic with same-day results. The Initiative is also backed by an advisory group that will help set the venture's priorities and an outside technical-advisory group of global-health-policy experts, scientists and specialists in infectious-disease diagnostics. Organizations working on diagnostics need reliable, scalable compute power, which we can deliver to them along with industry-leading services like analytics and machine learning, so they can process and analyze large data sets and iterate quickly," Teresa Carlson, vice president for AWS' worldwide public sector business, wrote in a blog post announcing the DDI. While the emphasis initially will be on COVID-19, the initiative will also consider other infectious-disease diagnostic projects, and is open to researchers and organizations around the world.